The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Jun Fang; Quintin J. Quinones; Trevor L. Holman; Michael J. Morowitz; Qun Wang; Huaqing Zhao; Frank Sivo; John M. Maris; Miriam L. Wahl

doi:10.1124/mol.106.026245

Research ArticleArticle

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Jun Fang, Quintin J. Quinones, Trevor L. Holman, Michael J. Morowitz, Qun Wang, Huaqing Zhao, Frank Sivo, John M. Maris and Miriam L. Wahl

Molecular Pharmacology December 2006, 70 (6) 2108-2115; DOI: https://doi.org/10.1124/mol.106.026245

Jun Fang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Quintin J. Quinones

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Trevor L. Holman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Morowitz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Qun Wang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Huaqing Zhao

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank Sivo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John M. Maris

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miriam L. Wahl

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Molecular Pharmacology

Vol. 70, Issue 6

1 Dec 2006

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Jun Fang, Quintin J. Quinones, Trevor L. Holman, Michael J. Morowitz, Qun Wang, Huaqing Zhao, Frank Sivo, John M. Maris and Miriam L. Wahl

Molecular Pharmacology December 1, 2006, 70 (6) 2108-2115; DOI: https://doi.org/10.1124/mol.106.026245

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Jun Fang, Quintin J. Quinones, Trevor L. Holman, Michael J. Morowitz, Qun Wang, Huaqing Zhao, Frank Sivo, John M. Maris and Miriam L. Wahl

Molecular Pharmacology December 1, 2006, 70 (6) 2108-2115; DOI: https://doi.org/10.1124/mol.106.026245

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Plain text

Vertical Tabs

Jump to comment:

In this issue

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Citation Manager Formats

The H⁺-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals